4 hours TransMedics Group (NASDAQ:TMDX) Given “Overweight” Rating at Piper Sandler MarketBeat
Piper Sandler restated an “overweight” rating and set a $180.00 price target on shares of TransMedics Group in a report on Monday.
Piper Sandler restated an “overweight” rating and set a $180.00 price target on shares of TransMedics Group in a report on Monday.